This grant is for the purpose of encouraging behavioral intervention development research. It aims to support projects that test efficacy, conduct clinical trials, and examine mechanisms of behavior change. Researchers can explore dose-response, treatment optimization, and sequencing of behavioral, combined, or integrated behavioral and pharmacological interventions. Specific areas of interest include drug abuse treatment, especially for patients with comorbidities, and interventions to improve adherence to treatment. The program also seeks proposals for technology-boosted interventions, those preventing HIV transmission among drug users, and strategies promoting adherence to HIV and addiction medications. Furthermore, it supports interventions addressing substance misuse and chronic pain, with a focus on Stage II and Stage III efficacy research.
Opportunity ID: 356515
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-299 |
| Funding Opportunity Title: | Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 24, 2024 |
| Last Updated Date: | Sep 24, 2024 |
| Original Closing Date for Applications: | May 07, 2025 |
| Current Closing Date for Applications: | May 07, 2025 |
| Archive Date: | Jun 12, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Special district governments Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage II and Stage III efficacy research. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-299.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356515 Full Announcement-PAR-24-299 -> PAR-24-299-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288380 | Jan 05, 2025 | May 07, 2025 | View |
Package 1
Mandatory forms
356515 RR_SF424_5_0-5.0.pdf
356515 PHS398_CoverPageSupplement_5_0-5.0.pdf
356515 RR_OtherProjectInfo_1_4-1.4.pdf
356515 PerformanceSite_4_0-4.0.pdf
356515 RR_KeyPersonExpanded_4_0-4.0.pdf
356515 PHS398_ResearchPlan_5_0-5.0.pdf
356515 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356515 RR_Budget_3_0-3.0.pdf
356515 RR_SubawardBudget30_3_0-3.0.pdf
356515 PHS398_ModularBudget_1_2-1.2.pdf
356515 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
